keyword
https://read.qxmd.com/read/38641474/natural-history-and-health-care-burden-of-non-curative-treatment-for-muscle-invasive-bladder-cancer
#1
JOURNAL ARTICLE
Haim Herzberg, Yossi Ventura, Karin Lifshitz, Ziv Savin, Shay Golan, Jack Baniel, Ofer Yossepowitch, Roy Mano
OBJECTIVE: Muscle-invasive bladder cancer is an aggressive disease. Yet, many patients, especially those with advanced age and multiple comorbidities, do not receive treatment with curative intent. We evaluated the disease course and health care burden of these patients. MATERIALS AND METHODS: Bi-center, retrospective analysis of patients diagnosed with muscle-invasive bladder cancer who did not undergo curative-intent treatment (radical cystectomy or trimodal therapy) between 2016 and 2021...
April 18, 2024: Urologic Oncology
https://read.qxmd.com/read/38636951/a-prognostic-survival-model-incorporating-patient-reported-outcomes-for-transplant-ineligible-patients-with-multiple-myeloma
#2
JOURNAL ARTICLE
Hira Mian, Hsien Seow, Amaris K Balitsky, Matthew C Cheung, Anastasia Gayowsky, Jason Tay, Tanya M Wildes, Arleigh McCurdy, Alissa Visram, Irwindeep Sandhu, Rinku Sutradhar
Developing prognostic tools specifically for patients themselves represents an important step in empowering patients to engage in shared decision-making. Incorporating patient-reported outcomes may improve the accuracy of these prognostic tools. We conducted a retrospective population-based study of transplant-ineligible (TIE) patients with multiple myeloma (MM) diagnosed between January 2007 and December 2018. A multivariable Cox regression model was developed to predict the risk of death within 1-year period from the index date...
April 18, 2024: Oncologist
https://read.qxmd.com/read/38635421/high-financial-hardship-among-patients-with-advanced-ovarian-cancer
#3
JOURNAL ARTICLE
Elsa Maria Vasquez-Trespalacios, Jessica N Rivera Rivera, McKenzie McIntyre, Waleska Santiago-Datil, Robert M Wenham, Susan T Vadaparampil, Andrea L Buras, Claire C Conley
Ovarian cancer is considered the most fatal and costly gynecologic cancer. Although personalized therapies have improved ovarian cancer prognosis, they have resulted in increased financial toxicity concerns among this population. This study evaluated financial toxicity in patients with advanced ovarian cancer. Using secondary data from a study of barriers to palliative care, financial toxicity (FT) was measured through the Comprehensive Score for Financial Toxicity scale. Univariate and bivariate analyses were used to assess the relationship between selected demographic (i...
April 18, 2024: Journal of Social Work in End-of-life & Palliative Care
https://read.qxmd.com/read/38634814/the-impact-of-advancing-the-standard-of-care-in-radiotherapy-on-operational-treatment-resources
#4
JOURNAL ARTICLE
Michael Roumeliotis, Kundan Thind, Hali Morrison, Ben Burke, Kevin Martell, Lukas van Dyke, Lisa Barbera, Sarah Quirk
PURPOSE: To demonstrate the impact of implementing hypofractionated prescription regimens and advanced treatment techniques on institutional operational hours and radiotherapy personnel resources in a multi-institutional setting. The study may be used to describe the impact of advancing the standard of care with modern radiotherapy techniques on patient and staff resources. METHODS: This study uses radiation therapy data extracted from the radiotherapy information system from two tertiary care, university-affiliated cancer centers from 2012 to 2021...
April 18, 2024: Journal of Applied Clinical Medical Physics
https://read.qxmd.com/read/38633827/the-potential-role-of-precision-medicine-to-alleviate-racial-disparities-in-prostate-bladder-and-renal-urological-cancer-care
#5
REVIEW
Kunal K Sindhu, Zachary Dovey, Marcher Thompson, Anthony D Nehlsen, Karin A Skalina, Beata Malachowska, Shaakir Hasan, Chandan Guha, Justin Tang, Lucas Resende Salgado
BACKGROUND: Racial disparities in oncological outcomes resulting from differences in social determinants of health (SDOH) and tumour biology are well described in prostate cancer (PCa) but similar inequities exist in bladder (BCa) and renal cancers (RCCs). Precision medicine (PM) aims to provide personalized treatment based on individual patient characteristics and has the potential to reduce these inequities in GU cancers. OBJECTIVE: This article aims to review the current evidence outlining racial disparities in GU cancers and explore studies demonstrating improved oncological outcomes when PM is applied to racially diverse patient populations...
April 2024: BJUI compass
https://read.qxmd.com/read/38630388/national-trends-in-the-treatment-of-adult-diffuse-midline-gliomas-a-rare-clinical-scenario
#6
JOURNAL ARTICLE
Jay Desai, Sujay Rajkumar, Matthew J Shepard, John Herbst, Stephen M Karlovits, Shakir Hasan, Zachary D Horne, Rodney E Wegner
PURPOSE: Diffuse midline gliomas (DMG) include all midline gliomas with a point mutation to the histone H3 gene resulting in the substitution of a lysine with a methionine (K27M). These tumors are classified as World Health Organization grade 4 with a mean survival between 9- and 19-months following diagnosis. There is currently no standard of care for DMG, and palliative radiation therapy has been proven to only extend survival by months. Our current study aims to report current treatment trends and predictors of the overall survival of DMG...
April 17, 2024: Journal of Neuro-oncology
https://read.qxmd.com/read/38629578/understanding-and-overcoming-resistance-to-immunotherapy-in-genitourinary-cancers
#7
REVIEW
Sean T Evans, Yash Jani, Caroline S Jansen, Ahmet Yildirim, Ecem Kalemoglu, Mehmet Asim Bilen
The introduction of novel immunotherapies has significantly transformed the treatment landscape of genitourinary (GU) cancers, even becoming the standard of care in some settings. One such type of immunotherapy, immune checkpoint inhibitors (ICIs) like nivolumab, ipilimumab, pembrolizumab, and atezolizumab play a pivotal role by disturbing signaling pathways that limit the immune system's ability to fight tumor cells. Despite the profound impact of these treatments, not all tumors are responsive. Recent research efforts have been focused on understanding how cancer cells manage to evade the immune response and identifying the possible mechanisms behind resistance to immunotherapy...
December 31, 2024: Cancer Biology & Therapy
https://read.qxmd.com/read/38627736/exploring-treatment-outcomes-in-stage-ii-iii-rectal-cancer-patients-undergoing-neoadjuvant-therapy-at-a-tertiary-care-center-in-pakistan-a-comprehensive-analysis-of-pathological-outcomes
#8
JOURNAL ARTICLE
Misbah Younus Soomro, Saqib Raza Khan, Hafiz Muhammad, Sujjawal Ahmad, Nawazish Zehra, Insia Ali, Mirza Rameez Samar, Arif Hameed, Munira Moosajee, Yasmin Abdul Rashid
BACKGROUND: Rectal cancer treatment has transformed in recent years, with neoadjuvant treatment (NT) and total neoadjuvant treatment (TNT) aiming to enhance pathological responses. This pioneering study in our country delves into rectal cancer management, offering crucial insights by examining pathological outcomes in patients treated with the NT and TNT approach, shaping the evolving landscape. METHODS: In this retrospective-cohort study spanning January 2017 to December 2022 at a tertiary care hospital in Pakistan, ethical approval was obtained to examine outcomes of two treatments...
April 16, 2024: BMC Cancer
https://read.qxmd.com/read/38623813/eliciting-the-views-of-left-breast-cancer-patients-receiving-deep-inspiration-breath-hold-radiation-therapy-to-inform-the-design-of-multimedia-education-and-improve-patient-centred-care-for-prospective-patients
#9
JOURNAL ARTICLE
Kathleene Dower, Georgia K B Halkett, Haryana Dhillon, Diana Naehrig, Moira O'Connor
INTRODUCTION: The currently accepted best practice radiation treatment for left breast cancer patients is Deep Inspiration Breath Hold (DIBH) where patients hold a deep breath to reduce late cardiac and pulmonary effects from treatment. DIBH can be challenging and induce or exacerbate anxiety in patients due to the perceived pressure to reduce radiation treatment side effects. This study explored the experiences of patients treated with Deep Inspiration Breath Hold Radiation Therapy (DIBH-RT) to improve patient-centred care and inform the design of multimedia educational tools for future patients undergoing DIBH...
April 16, 2024: Journal of Medical Radiation Sciences
https://read.qxmd.com/read/38621608/impact-of-radiation-therapy-modalities-on-loco-regional-control-in-inflammatory-breast-cancer
#10
JOURNAL ARTICLE
Maximilien Rogé, Youlia Kirova, Emilie Lévêque, Marin Guigo, Alison Johnson, Rafik Nebbache, Eleonor Rivin Del Campo, Ioana Lazarescu, Stéphanie Servagi, Augustin Mervoyer, Axel Cailleteau, Sébastien Thureau, Juliette Thariat
INTRODUCTION: In inflammatory breast cancer (IBC), radiotherapy intensification is considered a standard of care by some teams, although the level of evidence remains low. We sought to analyze the impact of radiotherapy modalities on the risk of loco-regional and distant relapse. METHODS: A retrospective multicenter study included patients with localized IBC treated between 2010 and 2017. Standard post-mastectomy radiotherapy consisted of daily fractions to a total dose of 50 Gy equivalent without a boost or bolus, while intensified radiotherapy referred to the use of a boost or bolus...
April 13, 2024: International Journal of Radiation Oncology, Biology, Physics
https://read.qxmd.com/read/38616815/efficacy-of-an-aloe-vera-chamomile-and-thyme-cosmetic-cream-for-the-prophylaxis-and-treatment-of-mild-dermatitis-induced-by-radiation-therapy-in-breast-cancer-patients-the-alantel-study
#11
JOURNAL ARTICLE
E Villegas-Becerril, C Jimenez-Garcia, L A Perula-de Torres, M Espinosa-Calvo, C M Bueno-Serrano, F Romero-Ruperto, F Gines-Santiago, M C Moreno-Manzanaro, J J Muñoz-Gavilan, G Montes-Redondo, M A Quesada-Roman, M C Linares-Ramirez, J M Parras-Rejano, N Muñoz-Alcaraz, M D Maestre-Serrano, E M Romero-Rodriguez
OBJECTIVES: Radiation-induced dermatitis (RD) is one of the most common toxicities in radiation therapy (RT) patients. Corticosteroids, immunosuppressants, and natural products (NPs) have been used as treatment. The objective was to evaluate the efficacy of a NPs-based cream (Alantel®) to reduce the incidence of RD in women with breast cancer undergoing RT treatment. DESIGN: We conducted a controlled, randomized, double-blind clinical trial. SETTING: Radiation Oncology Unit of the Reina Sofía Hospital and 5 Primary Care centers of the Cordoba and Guadalquivir Health District (Spain)...
June 2024: Contemporary Clinical Trials Communications
https://read.qxmd.com/read/38611019/cervical-cancer-associated-with-pregnancy-current-challenges-and-future-strategies
#12
REVIEW
Jennifer Le Guévelou, Lise Selleret, Enora Laas, Fabrice Lecuru, Manon Kissel
Cancer during pregnancy is defined as a tumor diagnosed in a pregnant woman or up to 1-year post-partum. While being a rare disease, cervical cancer is probably one of the most challenging medical conditions, with the dual stake of treating the cancer without compromising its chances for cure, while preserving the pregnancy and the health of the fetus and child. To date, guidelines for gynecological cancers are provided through international consensus meetings with expert panels, giving insights on both diagnosis, treatment, and obstetrical care...
March 29, 2024: Cancers
https://read.qxmd.com/read/38610122/factors-associated-with-adjuvant-treatment-delays-in-patients-treated-surgically-for-head-and-neck-cancer
#13
JOURNAL ARTICLE
Alan L Sticker, Sydney T Cannon, Gregory B Russell, Joshua D Waltonen
OBJECTIVE: To determine the patient and treatment characteristics associated with delay in post-operative radiation therapy (PORT) for patients treated surgically for head and neck squamous cell cancer (HNSCC) at our institution. DESIGN: Single institution retrospective review. SETTING: Tertiary care academic medical centre. PARTICIPANTS: Patients treated surgically for HNSCC who underwent PORT between 2013 and 2016...
April 12, 2024: Clinical Otolaryngology
https://read.qxmd.com/read/38610008/developing-an-educational-hub-impact-of-a-distance-learning-curriculum-in-a-multinational-cohort
#14
JOURNAL ARTICLE
Meridith L Balbach, Grantly Neely, Afua Yorke, Evangelina Figueroa-Medina, Jonathan Paly, Rebecca M Shulman, Claire Dempsey, Adam Shulman, Cesar Della Biancia, William B Cutrer, Benjamin C Li
PURPOSE: To address a gap in radiation oncology education in low- and middle-income countries (LMICs), we sought to evaluate the effectiveness and generalizability of a refined curriculum on intensity modulated radiotherapy (IMRT) offered to existing radiation therapy (RT) clinics across Africa and Latin America (LATAM) at no cost. METHODS: A curriculum was created based on prior needs assessments and adapted for participating medical physicists, radiation oncologists, radiation therapists, and trainees in LMICs...
April 12, 2024: BMC Medical Education
https://read.qxmd.com/read/38607778/observations-of-the-effectiveness-dosage-and-prognosis-of-intensity-modulated-radiation-therapy-under-ultrasonic-guidance-for-cervical-cancer-patients
#15
JOURNAL ARTICLE
Chenxi Li, Jian Li, Yao Lu, Jiahui Hou, Zhaoyu Zhi, Baocun Zhao, Xiumei Zhang
BACKGROUND: Volumetric modulated arc therapy (VMAT) guided by ultrasound is a novel radiation therapy technique that facilitates the delineation of the tumor target area under image guidance, enhancing the precision of radiation therapy and maximizing the protection of surrounding tissues. OBJECTIVE: The objective of this paper is to investigate the effectiveness of VMAT under ultrasonic guidance for cervical cancer patients and its impact on radiotherapy dosage and prognosis...
February 29, 2024: Technology and Health Care: Official Journal of the European Society for Engineering and Medicine
https://read.qxmd.com/read/38607445/perceived-control-self-management-efficacy-and-quality-of-life-in-patients-treated-with-radiation-therapy-for-breast-cancer-a-longitudinal-study
#16
JOURNAL ARTICLE
Hai-Mei Qu, Hong-Yue Zhong, Tian Xiao, Yan-Jun Li, Pan Ren, Xiao-Ju Chen
OBJECTIVE: This longitudinal study aims to examine the present state of perceived control, self-management efficacy, and overall quality of life (QoL) in patients with breast cancer undergoing radiotherapy, and gain insight into the dynamic trends and factors that influence the quality of life experienced by patients during the course of radiotherapy. METHODS: Participants completed the Cancer Experience and Efficacy Scale (CEES), Strategies Used by People to Promote Health (SUPPH), and Functional Assessment of Cancer Therapy- Breast (FACT-B)...
April 12, 2024: Supportive Care in Cancer
https://read.qxmd.com/read/38607014/microfluidics-based-technologies-for-the-assessment-of-castration-resistant-prostate-cancer
#17
REVIEW
Amel Sassi, Lidan You
Castration-resistant prostate cancer remains a significant clinical challenge, wherein patients display no response to existing hormone therapies. The standard of care often includes aggressive treatment options using chemotherapy, radiation therapy and various drugs to curb the growth of additional metastases. As such, there is a dire need for the development of innovative technologies for both its diagnosis and its management. Traditionally, scientific exploration of prostate cancer and its treatment options has been heavily reliant on animal models and two-dimensional (2D) in vitro technologies...
March 26, 2024: Cells
https://read.qxmd.com/read/38605158/novel-drug-delivery-approaches-for-the-localized-treatment-of-cervical-cancer
#18
REVIEW
Ivy Saha, Jitu Halder, Tushar Kanti Rajwar, Ritu Mahanty, Deepak Pradhan, Priyanka Dash, Chandan Das, Vineet Kumar Rai, Biswakanth Kar, Goutam Ghosh, Goutam Rath
Cervical cancer (CC) is the fourth leading cancer type in females globally. Being an ailment of the birth canal, primitive treatment strategies, including surgery, radiation, or laser therapy, bring along the risk of infertility, neonate mortality, premature parturition, etc. Systemic chemotherapy led to systemic toxicity. Therefore, delivering a smaller cargo of therapeutics to the local site is more beneficial in terms of efficacy as well as safety. Due to the regeneration of cervicovaginal mucus, conventional dosage forms come with the limitations of leaking, the requirement of repeated administration, and compromised vaginal retention...
April 11, 2024: AAPS PharmSciTech
https://read.qxmd.com/read/38604182/proton-beam-reirradiation-for-locally-recurrent-rectal-cancer-patients-with-prior-pelvic-irradiation
#19
JOURNAL ARTICLE
Yoshiaki Takagawa, Motohisa Suzuki, Ichiro Seto, Yusuke Azami, Masanori Machida, Kanako Takayama, Nor Shazrina Sulaiman, Tatsuhiko Nakasato, Yasuhiro Kikuchi, Masao Murakami, Michitaka Honda, Yasushi Teranishi, Koji Kono
The aim of the present study was to report the feasibility of proton beam reirradiation for patients with locally recurrent rectal cancer (LRRC) with prior pelvic irradiation. The study population included patients who were treated with proton beam therapy (PBT) for LRRC between 2008 and December 2019 in our institution. Those who had a history of distant metastases of LRRC, with or without treatment, before reirradiation, were excluded. Overall survival (OS), progression-free survival (PFS) and local control (LC) were estimated using the Kaplan-Meier method...
April 10, 2024: Journal of Radiation Research
https://read.qxmd.com/read/38603656/latin-american-consensus-on-the-treatment-of-head-and-neck-cancer
#20
REVIEW
Leandro Luongo Matos, Luiz Paulo Kowalski, Aline Lauda Freitas Chaves, Thiago Bueno de Oliveira, Gustavo Nader Marta, Maria Paula Curado, Gilberto de Castro Junior, Terence P Farias, Gustavo Sarria Bardales, Mario Avila Cabrera, Renato de Castro Capuzzo, Genival Barbosa de Carvalho, Claudio Roberto Cernea, Rogério Aparecido Dedivitis, Fernando Luiz Dias, Andrés Munyo Estefan, Agustin Horacio Falco, Gustavo Alberto Ferraris, Alejandro Gonzalez-Motta, Andre Guimarães Gouveia, Alexandre Arthur Jacinto, Marco Aurelio Vamondes Kulcsar, Ana Kober Leite, Renan Bezerra Lira, Milena Perez Mak, Pedro De Marchi, Evandro Sobroza de Mello, Fátima Cristina Mendes de Matos, Pablo H Montero, Eduardo Dias de Moraes, Fabio Ynoe de Moraes, Diego Chaves Rezende Morais, Fernando Miguel Poenitz, Adela Poitevin, Hernán Ortiz Riveros, Álvaro Sanabria, Miguel Ticona-Castro, José Guilherme Vartanian, Gustavo Viani, Eugenio F Vines, William Nassib William Junior, David Conway, Shama Virani, Paul Brennan
Head and neck squamous cell carcinoma (HNSCC) is well known as a serious health problem worldwide, especially in low-income countries or those with limited resources, such as most countries in Latin America. International guidelines cannot always be applied to a population from a large region with specific conditions. This study established a Latin American guideline for care of patients with head and neck cancer and presented evidence of HNSCC management considering availability and oncologic benefit. A panel composed of 41 head and neck cancer experts systematically worked according to a modified Delphi process on (1) document compilation of evidence-based answers to different questions contextualized by resource availability and oncologic benefit regarding Latin America (region of limited resources and/or without access to all necessary health care system infrastructure), (2) revision of the answers and the classification of levels of evidence and degrees of recommendations of all recommendations, (3) validation of the consensus through two rounds of online surveys, and (4) manuscript composition...
April 2024: JCO global oncology
keyword
keyword
38238
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.